A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1). (Q51629344)
Jump to navigation
Jump to search
scientific article published on 21 May 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1). |
scientific article published on 21 May 2015 |
Statements
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1) (English)
S Ramalingam
G Goss
R Rosell
G Schmid-Bindert
B Zaric
Z Andric
D Komov
T Ceric
F Khuri
M Samarzija
T Ciuleanu
V Hirsh
T Wehler
R Salgia
G Shapiro
E Sheldon
F Teofilovici
V Vukovic
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference